MEDVi
US$ 29.74
glp-1 prescriptions growth slowdown 2024 New Demand in an Old Market Monitoring Report: GLP-1 RA Prescribing
Description
As GLP-1s grow increasingly popular, people are becoming more curious about their effects, especially on how this medication impacts their workout gains
The median time-to-onset of gastrointestinal AEs was 1 (IQR 024) days, and 77.44% of the AEs occurred within 30 days after excluding invalid reports
However, compounded drugs are not FDA-approved and may be associated with higher safety concerns and product quality issues
[10] [11] The mechanism by which these medications reduce appetite involves both peripheral and central pathways
That said, less welcome shifts in your menstrual cycle are also possible
